DalsnaFinance › IPOs › Dyne Therapeutics Inc › IPO
Dyne Therapeutics, Inc. completed its initial public offering on NASDAQ on September 17, 2020, pricing at $19.00 a share.
| Ticker | DYN |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 17, 2020 |
| Offering price | $19.00 |
| Shares offered | 12,251,578 |
| Total raised | $233M |
Dyne Therapeutics, Inc. sold 12,251,578 shares at $19.00 each on NASDAQ. Multiplied out, that is $232.8 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $233 million total recorded for the deal.
Dyne Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Dyne Therapeutics, Inc.. This page is general information, not investment advice.